Genus Capital Management’s Cintas CTAS Stock Holding History

Genus Capital Management’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,740	Closed	-$3.24M	–	236
2024 Q4	$3.24M	Buy	+17,740	New	+$3.73M	0.44%	77

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Genus Capital Management's CTAS Position: Q4 2025 in Review

Genus Capital Management sold out of Cintas (CTAS) in Q4 2025, closing a stake of 1,672 shares — an estimated $343K sold.

Genus Capital Management first reported a position in CTAS in Q1 2025 and held it in 3 quarters. The position peaked at $6.7M in Q2 2025. 1,473 funds tracked by Wall St. Rank hold CTAS as of Q4 2025.

Genus Capital Management reported no remaining Cintas position as of Q4 2025 after selling out during the quarter.
Genus Capital Management sold 1,672 Cintas shares in Q4 2025, an estimated $343K.
Genus Capital Management first reported a position in Cintas in Q1 2025 and held it in 3 quarters.
Genus Capital Management's Cintas position peaked at $6.7M in Q2 2025.
1,473 funds tracked by Wall St. Rank held Cintas as of Q4 2025.

Based on Genus Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.